Abstract
The aim of this study is to investigate the associations of serum urea, creatinine and uric acid levels with clinical and laboratory characteristics, independent of lupus renal involvement in SLE patients. A total of 191 SLE patients were included in the present study. Some clinical and laboratory characteristics of the patients were obtained by medical record review. The results showed that serum urea, creatinine and uric acid levels seemed to be associated with several clinical and laboratory characteristics of SLE. However, multivariate logistical regression analysis indicated that increasing serum urea levels were positively associated with disease duration and thrombocytopenia, but negatively with arthritis and skin rash. Compared with quartile 1 of urea, the ORs of quartile 2, quartile 3 and quartile 4 were, respectively, 1.008 (0.997–1.015, P = 0.189), 1.010 (1.001–1.019, P = 0.038) and 1.014 (1.004–1.024, P = 0.008) with increasing disease duration; 1.912 (0.516–7.088, P = 0.332), 10.126 (2.771–36.997, P = 0.000) and 5.583 (1.285–24.266, P = 0.022) with thrombocytopenia; 0.864 (0.331–2.254, P = 0.765), 0.516 (0.18–1.475, P = 0.217) and 0.162 (0.047–0.557, P = 0.004) with arthritis; and 0.342 (0.135–0.868, P = 0.024), 0.215 (0.074–0.622, P = 0.005) and 0.332 (0.097–1.13, P = 0.078) with skin rash. Increasing serum creatinine levels were positively associated with sex, disease duration and SLEDAI, but negatively with skin rash. Compared with quartile 1 of creatinine, the ORs of quartile 2, quartile 3 and quartile 4 were, respectively, 2.993 (0.282–31.74, P = 0.363), 7.937 (0.861–73.18, P = 0.068) and 13.411 (1.32–36.246, P = 0.028) with male, 1.011 (1.002–1.02, P = 0.017), 1.002 (0.991–1.013, P = 0.684) and 1.018 (1.008–1.028, P = 0.001) with increasing disease duration; 1.112 (1.006–1.228, P = 0.038), 1.065 (0.959–1.183, P = 0.239) and 1.140 (1.022–1.272, P = 0.019) with increasing SLEDAI; and 0.303 (0.119–0.771, P = 0.012), 0.282 (0.104–0.76, P = 0.012) and 0.174 (0.052–0.584, P = 0.005) with skin rash. Increasing serum uric acid levels were only positively associated with erythrocytopenia. Compared with quartile 1 of uric acid, the ORs of quartile 2, quartile 3 and quartile 4 were, respectively, 0.910 (0.37–2.239, P = 0.837), 2.147 (0.901–5.116, P = 0.085) and 3.079 (1.211–7.828, P = 0.018) with erythrocytopenia. The present study demonstrated that, except for reflecting renal function, serum urea, creatinine and uric acid exert separate clinical significances in SLE.
Similar content being viewed by others
References
Fairhurst AM, Wandstrat AE, Wakeland EK (2006) Systemic lupus erythematosus: multiple immunologic phenotypes in a complex genetic disease. Adv Immunol 92:1–69
Rothfield N, Sontheimer RD, Bernstein M (2006) Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 24:348–362
Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. New Engl J Med 358:929–939
Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, For the Lupus Nephritis Collaborative Study Group (2000) Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 35:904–914
Yang Z, Liang Y, Xi W, Zhu Y, Li C, Zhong R (2011) Association of serum uric acid with lupus nephritis in systemic lupus erythematosus. Rheumatol Int 31(6):743–748
de Castro WP, Morales JV, Wagner MB, Graudenz M, Edelweiss MI, Goncalves LF (2007) Hypertension and Afro-descendant ethnicity: a bad interaction for lupus nephritis treated with cyclophosphamide? Lupus 16:724–730
Kwok SK, Ju JH, Cho CS, Kim HY, Park SH (2009) Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus 18(1):16–21
Mok CC, Lee KW, Ho CTK, Lau CS, Wong WS (2000) A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology 39:399–406
Scofield RH, Bruner GR, Kelly JA, Kilpatrick J, Bacino D, Nath SK, Harley JB (2003) Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood 101:992–997
Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS, For the LUMINA Study Group (2007) Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. Rheumatology 46:1471–1476
Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
Pan HF, Ye DQ, Wang Q, Li WX, Zhang N, Li XP, Xu JH, Dai H (2008) Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients. Clin Rheumatol 27:339–343
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, The Committee on Prognosis Studies in SLE (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630–640
de Carvalho JF, do Nascimento AP, Testagrossa LA, Barros RT, Bonfa E (2010) Male gender results in more severe lupus nephritis. Rheumatol Int (in press)
Diamandopoulos AA, Goudas PC (2001) Substitution of renal function through skin catharsis: evidence from the classical period to the middle ages. Kidney Int 59:1580–1589
Hasan T, Pertovaara M, Yli-Kerttula U, Luukkaala T, Korpela M (2004) Seasonal variation of disease activity of systemic lupus erythematosus in Finland: a 1 year follow up study. Ann Rheum Dis 63:1498–1500
Sturfelt G, Nived O (1985) Clinical inconsistency, benign course and normal employment rates in unselected systemic lupus erythematosus. Clin Exp Rheuamtol 3:303–310
Wysenbeek AJ, Black DA, Eries LE (1989) Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis 48:461–463
Amit M, Molad Y, Kiss S, Wysenbeek AJ (1997) Seasonal variations in manifestations and activity of systemic lupus erythematosus. Br J Rheumatol 36:449–452
Pistiner M, Wallace DJ, Nessim S, Metzger AI, Klineberg JR (1991) Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 21:55–64
Reveille JD, Bartolucci A, Alarcon GS (1990) Prognosis in systemic lupus erythematosus: negative impact of increasing age of onset, black race and thrombocytopenia as well as caused of death. Arthritis Rheum 33:37–48
Abu-Shakra M, Urowitz BM, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22:1265–1270
Massardo L, Martinez M, Jacobelli S (1994) Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 24:1–11
Glannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG (2006) Anaemia in systemic lupous erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis 65:144–148
Voulgarelis M, Kokori SI, Ioannidis JP, Tzioufas AG, Kyriaki D, Moutsopoulos HM (2000) Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis 59:217–222
Reynolds MD (1983) Gout and hyperuricemia associated with sickle-cell anemia. Semin Arthritis Rheum 12:404–413
Ball GV, Sorensen LB (1970) The pathogenesis of hyperuricemia and gout in sickle cell anemia. Arthritis Rheum 13:846–848
Rothschild BM, Sienknecht CW, Kaplan SB, Spindler JS (1980) Sickle cell disease associated with uric acid deposition disease. Ann Rheum Dis 39:392–395
Acknowledgments
This study was supported by a grant from the China National Natural Science Foundation Council (81001333).
Conflict of interest
No conflict of Interest has been declared by the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Zaixing Yang and Yan Liang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yang, Z., Liang, Y., Li, C. et al. Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus. Rheumatol Int 32, 2715–2723 (2012). https://doi.org/10.1007/s00296-011-1987-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1987-7